Cargando…

Multivariate indicators of disease severity in COVID-19

The novel coronavirus pandemic continues to cause significant morbidity and mortality around the world. Diverse clinical presentations prompted numerous attempts to predict disease severity to improve care and patient outcomes. Equally important is understanding the mechanisms underlying such diverg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bean, Joe, Kuri-Cervantes, Leticia, Pennella, Michael, Betts, Michael R., Meyer, Nuala J., Hassan, Wail M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054197/
https://www.ncbi.nlm.nih.gov/pubmed/36991002
http://dx.doi.org/10.1038/s41598-023-31683-9
_version_ 1785015610135019520
author Bean, Joe
Kuri-Cervantes, Leticia
Pennella, Michael
Betts, Michael R.
Meyer, Nuala J.
Hassan, Wail M.
author_facet Bean, Joe
Kuri-Cervantes, Leticia
Pennella, Michael
Betts, Michael R.
Meyer, Nuala J.
Hassan, Wail M.
author_sort Bean, Joe
collection PubMed
description The novel coronavirus pandemic continues to cause significant morbidity and mortality around the world. Diverse clinical presentations prompted numerous attempts to predict disease severity to improve care and patient outcomes. Equally important is understanding the mechanisms underlying such divergent disease outcomes. Multivariate modeling was used here to define the most distinctive features that separate COVID-19 from healthy controls and severe from moderate disease. Using discriminant analysis and binary logistic regression models we could distinguish between severe disease, moderate disease, and control with rates of correct classifications ranging from 71 to 100%. The distinction of severe and moderate disease was most reliant on the depletion of natural killer cells and activated class-switched memory B cells, increased frequency of neutrophils, and decreased expression of the activation marker HLA-DR on monocytes in patients with severe disease. An increased frequency of activated class-switched memory B cells and activated neutrophils was seen in moderate compared to severe disease and control. Our results suggest that natural killer cells, activated class-switched memory B cells, and activated neutrophils are important for protection against severe disease. We show that binary logistic regression was superior to discriminant analysis by attaining higher rates of correct classification based on immune profiles. We discuss the utility of these multivariate techniques in biomedical sciences, contrast their mathematical basis and limitations, and propose strategies to overcome such limitations.
format Online
Article
Text
id pubmed-10054197
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100541972023-03-29 Multivariate indicators of disease severity in COVID-19 Bean, Joe Kuri-Cervantes, Leticia Pennella, Michael Betts, Michael R. Meyer, Nuala J. Hassan, Wail M. Sci Rep Article The novel coronavirus pandemic continues to cause significant morbidity and mortality around the world. Diverse clinical presentations prompted numerous attempts to predict disease severity to improve care and patient outcomes. Equally important is understanding the mechanisms underlying such divergent disease outcomes. Multivariate modeling was used here to define the most distinctive features that separate COVID-19 from healthy controls and severe from moderate disease. Using discriminant analysis and binary logistic regression models we could distinguish between severe disease, moderate disease, and control with rates of correct classifications ranging from 71 to 100%. The distinction of severe and moderate disease was most reliant on the depletion of natural killer cells and activated class-switched memory B cells, increased frequency of neutrophils, and decreased expression of the activation marker HLA-DR on monocytes in patients with severe disease. An increased frequency of activated class-switched memory B cells and activated neutrophils was seen in moderate compared to severe disease and control. Our results suggest that natural killer cells, activated class-switched memory B cells, and activated neutrophils are important for protection against severe disease. We show that binary logistic regression was superior to discriminant analysis by attaining higher rates of correct classification based on immune profiles. We discuss the utility of these multivariate techniques in biomedical sciences, contrast their mathematical basis and limitations, and propose strategies to overcome such limitations. Nature Publishing Group UK 2023-03-29 /pmc/articles/PMC10054197/ /pubmed/36991002 http://dx.doi.org/10.1038/s41598-023-31683-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bean, Joe
Kuri-Cervantes, Leticia
Pennella, Michael
Betts, Michael R.
Meyer, Nuala J.
Hassan, Wail M.
Multivariate indicators of disease severity in COVID-19
title Multivariate indicators of disease severity in COVID-19
title_full Multivariate indicators of disease severity in COVID-19
title_fullStr Multivariate indicators of disease severity in COVID-19
title_full_unstemmed Multivariate indicators of disease severity in COVID-19
title_short Multivariate indicators of disease severity in COVID-19
title_sort multivariate indicators of disease severity in covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054197/
https://www.ncbi.nlm.nih.gov/pubmed/36991002
http://dx.doi.org/10.1038/s41598-023-31683-9
work_keys_str_mv AT beanjoe multivariateindicatorsofdiseaseseverityincovid19
AT kuricervantesleticia multivariateindicatorsofdiseaseseverityincovid19
AT pennellamichael multivariateindicatorsofdiseaseseverityincovid19
AT bettsmichaelr multivariateindicatorsofdiseaseseverityincovid19
AT meyernualaj multivariateindicatorsofdiseaseseverityincovid19
AT hassanwailm multivariateindicatorsofdiseaseseverityincovid19